ArticleBMC oral health2026
Microhardness and structural changes in calcium silicate-based sealers after short-term exposure to EDTA and organic acids: an in vitro study.
Article in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCalcium silicate-based root canal sealers are widely used because of their bioactivity and favorable properties. However, their resistance to chemical challenge and the role of chelating and acidic solutions in retreatment remain unclear. This study evaluated the effects of short-term EDTA and organic acids exposure on the microhardness and structure of two sealers (CeraSeal and TotalFill BC Sealer) and explored the underlying mechanisms.
methodsA total of 160 disc-shaped samples (80 per sealer) were prepared and incubated at 37 °C and 100% relative humidity. Vickers microhardness was measured weekly. X-ray diffraction (XRD) analyses were performed at weekly intervals using different samples, starting from the first measurable microhardness and continuing during material maturation. The final microhardness was defined as the plateau in value. After the final microhardness was reached, the samples were immersed for 5 min in 17% ethylenediaminetetraacetic acid, 10% citric acid, 10% formic acid, or distilled water to simulate retreatment conditions. Postexposure microhardness, phase changes, and surface morphology were evaluated via Vickers hardness testing, X-ray diffraction (XRD), and scanning electron microscopy (SEM), respectively. Statistical analyses included the Shapiro-Wilk test, t tests or nonparametric equivalents, one-way and Welch's ANOVA, and linear mixed model analysis (p < 0.05).
resultsCeraSeal appeared to reach its final microhardness earlier than TotalFill BC Sealer did, whereas TotalFill BC Sealer tended to exhibit higher ultimate microhardness values. Exposure to the test solutions significantly reduced the microhardness of both sealers (p < 0.001), with the greatest reductions observed in the formic acid (58%) and citric acid (52%) groups. XRD and SEM analyses suggested dissolution of the calcium silicate hydrate and calcium carbonate phases, increased surface porosity, and a possible tetragonal-to-monoclinic zirconia transformation in TotalFill BC Sealer, whereas no clear evidence of zirconia phase transformation was observed in CeraSeal.
conclusionsWithin the limitations of this in vitro study, TotalFill BC Sealer presented higher final microhardness values; however, it was more susceptible to structural degradation following exposure to the test solutions, which was associated with a marked reduction in microhardness values. In contrast, CeraSeal, despite demonstrating a lower final microhardness, exhibited comparatively smaller percentage reductions after solution exposure, suggesting relatively greater resistance to solution-induced degradation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.